Found: 7
Select item for more details and to access through your institution.
EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old.
- Published in:
- Allergy, 2022, v. 77, n. 1, p. 17, doi. 10.1111/all.15030
- By:
- Publication type:
- Article
Dissemination of EAACI food allergy guidelines using a flexible, practical, whole school allergy awareness toolkit.
- Published in:
- Allergy, 2021, v. 76, n. 11, p. 3479, doi. 10.1111/all.14871
- By:
- Publication type:
- Article
EAACI Biologicals Guidelines—dupilumab for children and adults with moderate‐to‐severe atopic dermatitis.
- Published in:
- Allergy, 2021, v. 76, n. 4, p. 988, doi. 10.1111/all.14690
- By:
- Publication type:
- Article
Allergy to Peanuts imPacting Emotions And Life (APPEAL): The impact of peanut allergy on children, teenagers, adults and caregivers in the UK and Ireland.
- Published in:
- PLoS ONE, 2022, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0262851
- By:
- Publication type:
- Article
Adrenaline auto‐injector prescription for patients at risk of anaphylaxis: BSACI guidance for primary care.
- Published in:
- Clinical & Experimental Allergy, 2023, v. 53, n. 9, p. 951, doi. 10.1111/cea.14325
- By:
- Publication type:
- Article
BSACI guideline for the set‐up of penicillin allergy de‐labelling services by non‐allergists working in a hospital setting.
- Published in:
- Clinical & Experimental Allergy, 2022, v. 52, n. 10, p. 1135, doi. 10.1111/cea.14217
- By:
- Publication type:
- Article
Allergy support.
- Published in:
- Community Practitioner, 2016, v. 89, n. 2, p. 24
- By:
- Publication type:
- Article